Our partner Jim Robertson is the featured speaker on the Hospital Finance Podcast episode “Thinking Outside the Box on Challenging State DSH Subsidies,” which is now available online on the Besler website and on major podcast platforms including iTunes, Spotify, Google Podcasts, Stitcher and SoundCloud. Highlights of the episode include a review of the Takings

The COVID-19 pandemic created a paradigm shift in the world of medicine with the increased use of telehealth and telemedicine to meet the challenge of expanding the delivery methods patients used to access health care. Although the federal Public Health Emergency related to COVID has now ended, telehealth providers must continue to monitor developments in

Considerable literature has emerged concerning the impact of the extended COVID-19 pandemic on the ability to handle stress and sustain mental health. Healthcare professionals are among the most vulnerable segments of the population to these consequences of the pandemic. There are numerous studies and reports of stress, sleep disturbances, and increased mood and anxiety symptoms

As we advised in a previous post on this blog, the Garden State Commercial Property Assessed Clean Energy (C-PACE) program was established by the New Jersey Economic Development Authority (EDA) as a mechanism to finance, among other things, commercial renewable energy projects, energy efficiency initiatives, electric vehicle charging stations, microgrids, power purchase agreements, as well

On January 5, 2023, the Federal Trade Commission (FTC) published a notice of proposed rulemaking (NPR) for a non-compete clause rule. The NPR, if approved as published, would ban as an unfair method of competition all non-compete clauses between an employer and workers in all industry sectors throughout the country. The NPR might also extend

In August 2022, President Biden signed into law the Inflation Reduction Act. The Act’s key provisions include the ability of the federal government to negotiate certain prescription drug pricing. Specifically, the law created a program that allows the federal government to negotiate prices for a limited number of high-cost single-source drugs (lacking generic and/or biosimilar

On March 9, 2023, the New Jersey State Board of Medical Examiners filed an Order and statement of reasons for denying reinstatement of a physician’s medical license that had been previously revoked but with a right to apply for reinstatement. The denial was based on the Board’s conclusion that N.J.S.A. 45:1-15.9 barred reinstatement because of

In light of the New Jersey Appellate Division’s recent decision in County of Passaic v. Horizon Healthcare Services affirming the validity of a commercial arbitration agreement that did not contain a jury waiver, contracting entities including those in the healthcare sector need to approach language differently depending on whether they are dealing with a consumer